Celtic Biotech Ltd
Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor binding proteins found in snake venom, these product candidates have the potential to increase survival, improve quality-of-life and reduce treatment costs for cancer patients. Celtic Biotech is focusing its research on solid tumours, including non-small-cell lung cancer (NSCLC), as its initial targets. The Company's lead candidate, CB-24 (Crotoxin), has been observed to be highly toxic to various tumour cell lines in pre-clinical and early clinical studies.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
1
organic / mo
Sign up free to see all 3 verified contacts at Celtic Biotech Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- JR
John Reid
Director · Research & Development
EmailPhone - PR
Paul Reid
Chief Executive Officer · General Business & Management
EmailPhone - PR
Paul Reid
Chief Executive Officer · General Business & Management
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Celtic Biotech Ltd
2 distinct titles indexed · top 2 shown.
- 2chief executive officer
- 1director
Sign up to unlock all 3 contacts at Celtic Biotech Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Celtic Biotech Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.